Tag: cardiovascular disease

Renova Therapeutics Announces Issuance of Patent Covering Delivery and Expression of Paracrine Genes

SAN DIEGO, March 27, 2018 /PRNewswire/ — Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced today that the European Patent Office has issued Patent No. 2814513, “Systemic Delivery and Regulated Expression of Paracrine Genes for […]